Concerns about the approval of lecanemab for Alzheimer's disease

Affiliations

• ¹ University of Reims Champagne-Ardenne, Reims, France.
• ² Department of Neurology, Santa Maria University Hospital, Terni, Italy.
• ³ Patient author, Iceland.
• ⁴ Department of Neurology, University of Florence, Florence, Italy.
• ⁵ IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
• ⁶ Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
• ⁷ Department of Neurology, Radboud University Medical Centre, Nijmegen, Netherlands.
• ⁸ Department of Public and Occupational Health, Amsterdam UMC, Amsterdam, Netherlands.
• ⁹ Neuro Centre, University Hospital Bonn, Bonn, Germany.
• ¹⁰ German Centre for Neurodegenerative Diseases (DZNE), Bonn, Germany.
• ¹¹ Departments of Epidemiology and Radiology and Nuclear Medicine, Erasmus University Medical Centre, Rotterdam, Netherlands.